Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses

Estimating Utility Values for Health States of Type 2 Diabetic Patients Using the EQ-5D (UKPDS 62)

Philip Clarke, Alastair Gray, Rury R. Holman · Medical Decision Making · 2002 · 425 citations

Estimating Utility Values for Health States of Type 2 Diabetic Patients Using the EQ-5D (UKPDS 62)

Philip Clarke, Alastair Gray, Rury R. Holman · Medical Decision Making · 2002 · 419 citations

Diabetes Management, Health Economics, Health Policy +8

Rates and correlates of employment in people with schizophrenia in the UK, France and Germany

Steven Marwaha, Sonia Johnson, Paul Bebbington et al. · The British Journal of Psychiatry · 2007 · 365 citations · Full text

The Impact of Weight Gain on Quality of Life Among Persons With Schizophrenia

David B. Allison, Joan Mackell, Diana D. McDonnell · Psychiatric Services · 2003 · 244 citations

Obesity, Quality Of Life, Mental Health Associations +14

Differential Effects of Risperidone, Olanzapine, Clozapine, and Conventional Antipsychotics on Type 2 Diabetes

Frank D. Gianfrancesco, Amy Grogg, Ramy Mahmoud et al. · The Journal of Clinical Psychiatry · 2002 · 237 citations